Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Gross Profit: 2012-2024

Historic Gross Profit for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to $345.7 million.

  • Ascendis Pharma A's Gross Profit rose 336.65% to $223.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $625.5 million, marking a year-over-year increase of 107.95%. This contributed to the annual value of $345.7 million for FY2024, which is 44.51% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Gross Profit of $345.7 million as of FY2024, which was up 44.51% from $239.2 million recorded in FY2023.
  • Ascendis Pharma A's 5-year Gross Profit high stood at $345.7 million for FY2024, and its period low was $4.9 million during FY2021.
  • Moreover, its 3-year median value for Gross Profit was $239.2 million (2023), whereas its average is $208.2 million.
  • Per our database at Business Quant, Ascendis Pharma A's Gross Profit plummeted by 47.00% in 2020 and then surged by 718.21% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Gross Profit (Yearly) stood at $7.9 million in 2020, then tumbled by 38.69% to $4.9 million in 2021, then soared by 718.21% to $39.8 million in 2022, then soared by 500.61% to $239.2 million in 2023, then skyrocketed by 44.51% to $345.7 million in 2024.